Aspen Aerogels (ASPN) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record 2024 results: revenue of $452.7M, Adjusted EBITDA of $89.9M, and net income of $13.4M, with revenue up 90% year-over-year and gross margins expanding to 40%.
Q4 2024 revenue was $123.1M, up 46% year-over-year, with net income of $11.4M and Adjusted EBITDA of $22.7M.
PyroThin thermal barrier revenue grew to $306.8M in 2024, with new OEM awards from Volvo Trucks and Mercedes-Benz, and Energy Industrial segment set quarterly records.
Transitioned to external manufacturing for Energy Industrial, exceeding gross margin targets and addressing tariff risks through pricing and sourcing strategies.
Ceased construction of Plant 2 in Georgia, shifting to modular capacity expansion at East Providence and external partners, reducing fixed costs by $8M per quarter.
Financial highlights
FY 2024 Adjusted EBITDA was $89.9M (20% margin), a $112.8M improvement year-over-year; Q4 Adjusted EBITDA was $22.7M (18% margin).
FY 2024 net income was $13.4M (3% margin), including a $27.5M one-time charge from convertible note redemption; Q4 net income was $11.4M (9% margin).
FY 2024 gross margin was 40%, up from 24% in 2023, with five consecutive quarters above 35%.
Ended 2024 with $220.9M in cash and $615M in shareholders' equity; generated $20.9M in free cash flow in Q4.
FY 2024 capital expenditures totaled $86.3M, down $89.2M from 2023, with $7.4M for Plant 2 and investments in Rhode Island and Mexico.
Outlook and guidance
Q1 2025 revenue expected between $75M-$95M, with gross profit margin target of 35%, Adjusted EBITDA between $0M-$15M, and net income ranging from a $15M loss to break-even.
Energy Industrial segment expected to deliver $35M-$40M in Q1 revenue; EV thermal barrier segment to cover the remainder.
CapEx for Q1 2025 (excluding Plant 2) projected at less than $7M; annual CapEx (excluding Plant 2) to be less than $25M.
Annual guidance withheld due to macro uncertainty; will provide quarterly updates as visibility improves.
Company focused on protecting profitability and capturing upside amid a broad range of demand outcomes.
Latest events from Aspen Aerogels
- Strong margin gains, new OEM launches, and DOE-backed expansion drive robust growth outlook.ASPN
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20249 Jul 2026 - All proposals passed, including director elections and board declassification.ASPN
AGM 202619 May 2026 - Q1 2026 revenue dropped, but net loss improved and strong cash reserves support recovery.ASPN
Q1 20268 May 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and board structure.ASPN
Proxy filing27 Mar 2026 - Proxy covers director elections, auditor ratification, executive pay, and board declassification.ASPN
Proxy filing27 Mar 2026 - Annual meeting covers director elections, pay, auditor ratification, and board declassification.ASPN
Proxy Filing13 Mar 2026 - Cost discipline, European wins, and energy industrial growth support 2026 recovery.ASPN
Q4 202525 Feb 2026 - Record Q2 revenue and profitability drive raised 2024 outlook and margin expansion.ASPN
Q2 20242 Feb 2026 - $225M debt facility redeems convertible note, lowers capital costs, and supports future growth.ASPN
Status Update23 Jan 2026